A framework that fine-tunes a general baseline model trained on publicly available data on small, class-specific datasets to retain the baseline’s generalization ability while gaining class-specific accuracy and produce probabilistic outputs that capture uncertainty in the training data is proposed.
Abstract
Deep learning models such as Chemprop have advanced quantitative molecular property prediction, but their reliance on large training sets limits use in data-scarce domains. We propose a framework that fine-tunes a general baseline model trained on publicly available data on small, class-specific datasets. The resulting models retain the baseline’s generalization ability while gaining class-specific accuracy and produce probabilistic outputs that capture uncertainty in the training data. We demonstrate the approach on three toxicity classes defined by a common core structure, target, or mode of action: (i) organophosphates, (ii) androgen receptor antagonists, and (iii) estrogen receptor β antagonists. Each fine-tuned model outperforms classical machine-learning methods and the EPA TEST tool. The probabilistic nature of the predictions enables prioritization of compounds for experimental validation and seamless integration with data streams of varying quality, supporting iterative decision-making in chemical safety and drug discovery.
This work presents a model validation framework consisting of five recommendations that would enable the community to move beyond aggregate metrics toward understanding where and why molecular property prediction models fail, and connects evaluation choices to real-world applications and case studies encountered in pha...
Srijit Seal, Akshat Shirish Zalte, David Alencar Araripe et al.· bioRxiv· 0 citations
Artificial intelligence-driven ADMET prediction is becoming a vital tool in lowering attrition, speeding up candidate prioritization, and influencing the direction of rational drug development, despite persistent issues with data quality, regulatory acceptance, and synthetic viability.
Satyam Kumar Vishwash, Ram Babu Soni, Ratima Sood et al.· Current Computer - Aided Dru...· 0 citations
This review discusses recent progress in ML, DL, and AI-based strategies for toxicity prediction, assesses their utility across major toxicity endpoints, and highlights the challenges and future research opportunities in predictive toxicology.
Anjali Mahavar, Atul Patel, Ashish Patel· Current Chemical Biology· 0 citations
Toxicity prediction in small molecules represents a fundamental challenge in drug development and chemical safety assessment. Traditional approaches heavily rely on predefined molecular descriptors or fingerprints, potentially limiting the ability to capture complex and nonlinear structure–activity relationships. Her...
N. Amoroso, E. Pantaleo, Fulvio Ciriaco et al.· Journal of Chemical Informat...· 0 citations
Monroe is presented, a new MFM with several innovations over the existing state of the art: increased scale allowing pre-training on over 81 million molecules from the PM6 quantum chemistry dataset; improved graph representation of stereochemistry; improved training losses including conformer denoising and embedding de...
Błażej Banaszewski, Andrew W. Fitzgibbon· 1 citation